Literature DB >> 17912104

Controlled study of lactoperoxidase gel on oral flora and saliva in irradiated patients with oral cancer.

Katalin Nagy1, Edit Urban, Olga Fazekas, Laszlo Thurzo, Elisabeth Nagy.   

Abstract

The aim of this study was to determine if radiotherapy induces hyposalivation altering oral microbial flora. The purpose of this placebo-controlled, single-blind study was to determine beneficial effects of a saliva substitute and an oral hygiene product on irradiated patients with oropharyngeal cancer. Eighteen patients were assigned to the test group (Biotène Oral Balance gel [Lacléde Incorporated Healthcare Products, Gardena, CA] and toothpaste used daily), and another 18 were put on a conventional daily regimen (carboxymethylcellulose gel and Oral-B toothpaste [Laclede Pharmaceuticals, Gardena, CA]). Cultures for identifying and quantitating microorganisms, whole unstimulated saliva, and visual analog measurements for comfort were obtained before mucositis occurred and after treatment. Daily use of Biotène products enhanced control of microbial flora, improved salivary flow, and increased oral comfort as compared with control subjects. Four weeks after mucositis, some aerobic isolates disappeared in the test group; periodontal-associated bacteria were markedly decreased in the test group; and candidal species were significantly lowered in the test group. Although baseline saliva was lower in the test group (P = 0.001), after 4 weeks, no difference between groups existed; comfort was greater in the test group (P = 0.007). Use of enzyme-engineered Biotène products that assist in control of the oral microbial flora as well as supporting oral comfort through lubrication appear to be useful aids for irradiated patients with oropharyngeal cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17912104     DOI: 10.1097/scs.0b013e3180de6311

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  9 in total

1.  Effects of a composition containing lactoferrin and lactoperoxidase on oral malodor and salivary bacteria: a randomized, double-blind, crossover, placebo-controlled clinical trial.

Authors:  Kouichirou Shin; Ken Yaegaki; Takatoshi Murata; Hisataka Ii; Tomoko Tanaka; Izumi Aoyama; Koji Yamauchi; Tomohiro Toida; Keiji Iwatsuki
Journal:  Clin Oral Investig       Date:  2010-05-29       Impact factor: 3.573

Review 2.  A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact.

Authors:  S B Jensen; A M L Pedersen; A Vissink; E Andersen; C G Brown; A N Davies; J Dutilh; J S Fulton; L Jankovic; N N F Lopes; A L S Mello; L V Muniz; C A Murdoch-Kinch; R G Nair; J J Napeñas; A Nogueira-Rodrigues; D Saunders; B Stirling; I von Bültzingslöwen; D S Weikel; L S Elting; F K L Spijkervet; M T Brennan
Journal:  Support Care Cancer       Date:  2010-03-25       Impact factor: 3.603

3.  Radioprotective effect of lactoferrin in mice exposed to sublethal X-ray irradiation.

Authors:  Li Feng; Jianguo Li; Ling Qin; Dan Guo; Hongyu Ding; Daping Deng
Journal:  Exp Ther Med       Date:  2018-08-03       Impact factor: 2.447

4.  Products based on olive oil, betaine, and xylitol in the post-radiotherapy xerostomia.

Authors:  Margarita Martín; Alicia Marín; Mario López; Olga Liñán; Felipe Alvarenga; David Büchser; Laura Cerezo
Journal:  Rep Pract Oncol Radiother       Date:  2016-11-25

Review 5.  Systematic review of basic oral care for the management of oral mucositis in cancer patients.

Authors:  Deborah B McGuire; Janet S Fulton; Jumin Park; Carlton G Brown; M Elvira P Correa; June Eilers; Sharon Elad; Faith Gibson; Loree K Oberle-Edwards; Joanne Bowen; Rajesh V Lalla
Journal:  Support Care Cancer       Date:  2013-09-10       Impact factor: 3.603

Review 6.  Saliva substitutes for the treatment of radiation-induced xerostomia--a review.

Authors:  Sebastian Hahnel; Michael Behr; Gerhard Handel; Ralf Bürgers
Journal:  Support Care Cancer       Date:  2009-06-04       Impact factor: 3.603

7.  Incidence and risk factors for infection in oral cancer patients undergoing different treatments protocols.

Authors:  Manju Panghal; Vivek Kaushal; Sangeeta Kadayan; Jaya Parkash Yadav
Journal:  BMC Oral Health       Date:  2012-07-20       Impact factor: 2.757

8.  Radioprotection of mice by lactoferrin against irradiation with sublethal X-rays.

Authors:  Yoshikazu Nishimura; Shino Homma-Takeda; Hee-Sun Kim; Izuru Kakuta
Journal:  J Radiat Res       Date:  2014-02-07       Impact factor: 2.724

Review 9.  How to improve the survival rate of implants after radiotherapy for head and neck cancer?

Authors:  Min Zheng; Li Li; Yaling Tang; Xin-Hua Liang
Journal:  J Periodontal Implant Sci       Date:  2014-02-26       Impact factor: 2.614

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.